Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Proteasome inhibition: a new therapeutic option in lupus nephritis?

Vlag, J. van der
Berden, J.H.M.

Publication date

January 2008

DOI

10.1093/ndt/gfn536

Publisher

Oxford University Press (OUP)

ISSN

0931-0509

Citation count (estimate)

15

Abstract

Contains fulltext : 71337.pdf (publisher's version ) (Open Access

Extracted data

Related items

Mycophenolate mofetil in the treatment of lupus nephritis

Patrick FK Yong
David P D&amp

June 2008

Patrick FK Yong1,2, David P D&rsquo;Cruz21Department of Clinical Immunology, Kings College Hospi...

Antihypertensives retarding progression of diabetic nephropathy

Elving, L.D.
Wetzels, J.F.M.
Lier, H.J.J. van
Nobel, E. de
Berden, J.H.M.

January 1995

Contains fulltext : 20866___.PDF (publisher's version ) (Open Access

Novel Therapeutic Interventions in Systemic Lupus Erythematosus

Athanassiou, Panagiotis
Athanassiou, Lambros
Kostoglou-Athanassiou, Ifigenia

May 2021

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease. It is characterized by a variab...

Renal replacement therapy in lupus nephritis.

Rietveld, A.
Berden, J.H.M.

January 2008

Contains fulltext : 71175.pdf (publisher's version ) (Open Access

Treatment of lupus nephritis.

Dolff, S.
Berden, J.H.M.
Bijl, M. van der

January 2010

Contains fulltext : 87620.pdf (publisher's version ) (Open Access)Renal involvemen...

Azathioprine, the Cinderella in the treatment of lupus nephritis.

Berden, J.H.M.

January 2009

Contains fulltext : 80401.pdf (publisher's version ) (Open Access

Discontinuation of immunosuppression in proliferative lupus nephritis: is it possible?

Grootscholten, C.
Berden, J.H.M.

January 2006

Contains fulltext : 51289.pdf (publisher's version ) (Open Access

The Proteasome Inhibitor Bortezomib Prevents Lupus Nephritis in the NZB/W F1 Mouse Model by Preservation of Glomerular and Tubulointerstitial Architecture

Hainz, Nadine
Thomas, Susanne
Neubert, Kirsten
Meister, Silke
Benz, Kerstin
Rauh, Manfred
Daniel, Christoph
Wiesener, Michael
Voll, Reinhard E.
Amann, Kerstin

June 2013

Background/Aims: Crucial steps in the initiation of lupus nephritis are the deposition of (auto-)ant...

Research Article The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation

August 2016

Copyright © 2014 Wei Huang et al. This is an open access article distributed under the Creative Comm...

A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.

Levidiotis, V.
Freeman, C.
Punler, M.
Martinello, P.
Creese, B.
Ferro, V.
Vlag, J. van der
Berden, J.H.M.
Parish, C.R.
Power, D.A.

January 2004

Contains fulltext : 57531.pdf (publisher's version ) (Open Access)The beta-D-endog...

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.

Grootscholten, C.
Ligtenberg, G.
Hagen, E.C.
Wall Bake, A.W. van den
Glas-Vos, J.W. de
Bijl, M.
Assmann, K.J.M.
Bruijn, J.A.
Weening, J.J.
Houwelingen, H.C. van
Derksen, R.H.W.M.
Berden, J.H.M.

January 2006

Contains fulltext : 50854.pdf (publisher's version ) (Closed access)Until recently...

Correspondence to

Pharmacodynamic Monitoring Of
A Sjoe M
Niewerth D
Et Al

January 2015

(immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nep...

PAPER The safety and efficacy of MMF in lupus nephritis: a pilot study

Ej Kingdon
Ag Mclean
E Psimenou
A Davenport
Sh Powis
P Sweny
A Burns

September 2016

Inducing and maintaining remission in patients with lupus nephritis may be difficult. Current treatm...

Proteasome inhibition: a new anti-inflammatory strategy

Elliott, Peter J.
Zollner, Thomas Matthias
Boehncke, Wolf-Henning

January 2003

The ubiquitin-proteasome pathway has a central role in the selective degradation of intracellular pr...

Treatment for lupus nephritis: A revisit

Tang, SCW
Lai, KN
Mok, CC

January 2005

The optimal treatment of severe lupus nephritis remains unclear. Regimens consisting of steroid and ...

Mycophenolate mofetil in the treatment of lupus nephritis

Patrick FK Yong
David P D&amp

June 2008

Patrick FK Yong1,2, David P D&rsquo;Cruz21Department of Clinical Immunology, Kings College Hospi...

Antihypertensives retarding progression of diabetic nephropathy

Elving, L.D.
Wetzels, J.F.M.
Lier, H.J.J. van
Nobel, E. de
Berden, J.H.M.

January 1995

Contains fulltext : 20866___.PDF (publisher's version ) (Open Access

Novel Therapeutic Interventions in Systemic Lupus Erythematosus

Athanassiou, Panagiotis
Athanassiou, Lambros
Kostoglou-Athanassiou, Ifigenia

May 2021

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease. It is characterized by a variab...

Renal replacement therapy in lupus nephritis.

Rietveld, A.
Berden, J.H.M.

January 2008

Contains fulltext : 71175.pdf (publisher's version ) (Open Access

Treatment of lupus nephritis.

Dolff, S.
Berden, J.H.M.
Bijl, M. van der

January 2010

Contains fulltext : 87620.pdf (publisher's version ) (Open Access)Renal involvemen...

Azathioprine, the Cinderella in the treatment of lupus nephritis.

Berden, J.H.M.

January 2009

Contains fulltext : 80401.pdf (publisher's version ) (Open Access

Discontinuation of immunosuppression in proliferative lupus nephritis: is it possible?

Grootscholten, C.
Berden, J.H.M.

January 2006

Contains fulltext : 51289.pdf (publisher's version ) (Open Access

The Proteasome Inhibitor Bortezomib Prevents Lupus Nephritis in the NZB/W F1 Mouse Model by Preservation of Glomerular and Tubulointerstitial Architecture

Hainz, Nadine
Thomas, Susanne
Neubert, Kirsten
Meister, Silke
Benz, Kerstin
Rauh, Manfred
Daniel, Christoph
Wiesener, Michael
Voll, Reinhard E.
Amann, Kerstin

June 2013

Background/Aims: Crucial steps in the initiation of lupus nephritis are the deposition of (auto-)ant...

Research Article The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation

August 2016

Copyright © 2014 Wei Huang et al. This is an open access article distributed under the Creative Comm...

A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.

Levidiotis, V.
Freeman, C.
Punler, M.
Martinello, P.
Creese, B.
Ferro, V.
Vlag, J. van der
Berden, J.H.M.
Parish, C.R.
Power, D.A.

January 2004

Contains fulltext : 57531.pdf (publisher's version ) (Open Access)The beta-D-endog...

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.

Grootscholten, C.
Ligtenberg, G.
Hagen, E.C.
Wall Bake, A.W. van den
Glas-Vos, J.W. de
Bijl, M.
Assmann, K.J.M.
Bruijn, J.A.
Weening, J.J.
Houwelingen, H.C. van
Derksen, R.H.W.M.
Berden, J.H.M.

January 2006

Contains fulltext : 50854.pdf (publisher's version ) (Closed access)Until recently...

Correspondence to

Pharmacodynamic Monitoring Of
A Sjoe M
Niewerth D
Et Al

January 2015

(immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nep...

PAPER The safety and efficacy of MMF in lupus nephritis: a pilot study

Ej Kingdon
Ag Mclean
E Psimenou
A Davenport
Sh Powis
P Sweny
A Burns

September 2016

Inducing and maintaining remission in patients with lupus nephritis may be difficult. Current treatm...

Proteasome inhibition: a new anti-inflammatory strategy

Elliott, Peter J.
Zollner, Thomas Matthias
Boehncke, Wolf-Henning

January 2003

The ubiquitin-proteasome pathway has a central role in the selective degradation of intracellular pr...

Treatment for lupus nephritis: A revisit

Tang, SCW
Lai, KN
Mok, CC

January 2005

The optimal treatment of severe lupus nephritis remains unclear. Regimens consisting of steroid and ...

Mycophenolate mofetil in the treatment of lupus nephritis

Patrick FK Yong
David P D&amp

June 2008

Patrick FK Yong1,2, David P D&rsquo;Cruz21Department of Clinical Immunology, Kings College Hospi...

Antihypertensives retarding progression of diabetic nephropathy

Elving, L.D.
Wetzels, J.F.M.
Lier, H.J.J. van
Nobel, E. de
Berden, J.H.M.

January 1995

Contains fulltext : 20866___.PDF (publisher's version ) (Open Access

Novel Therapeutic Interventions in Systemic Lupus Erythematosus

Athanassiou, Panagiotis
Athanassiou, Lambros
Kostoglou-Athanassiou, Ifigenia

May 2021

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease. It is characterized by a variab...